1. Home
  2. ACON vs JAGX Comparison

ACON vs JAGX Comparison

Compare ACON & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$2.48

Market Cap

3.0M

Sector

Technology

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.63

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACON
JAGX
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ACON
JAGX
Price
$2.48
$0.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$23.00
$60.00
AVG Volume (30 Days)
96.5K
371.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$11,689,000.00
Revenue This Year
$71.77
$22.41
Revenue Next Year
$80.52
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.75
52 Week Low
$0.61
$0.20
52 Week High
$21.31
$15.48

Technical Indicators

Market Signals
Indicator
ACON
JAGX
Relative Strength Index (RSI) 32.58 43.61
Support Level $2.34 $0.56
Resistance Level $7.98 $0.69
Average True Range (ATR) 0.20 0.05
MACD 0.07 0.02
Stochastic Oscillator 25.49 58.58

Price Performance

Historical Comparison
ACON
JAGX

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: